MAINTENANCE OF SKELETAL MUSCLES WHEN RECEIVING NEOADJUVANT CHEMOTHERAPY IMPROVES THE PROGNOSIS FOR PATIENTS WITH MUSCLE INVASIVE BLADDER CANCER

被引：0
|
作者：
Aoki, Maria
Naiki, Taku
Morikawa, Toshiharu
Isobe, Teruki
Gonda, Masakazu
Tomiyama, Nami
Shimizu, Nobuhiko
Noda, Yusuke
Nagai, Takashi
Banno, Rika
Nozaki, Satoshi
Etani, Toshiki
Ando, Ryosuke
Kawai, Noriyasu
Yasui, Takahiro
机构：
来源：
JOURNAL OF UROLOGY | 2023年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP22-04
引用
收藏
页码：E296 / E297
页数：2
相关论文
共 50 条
  • [1] Neoadjuvant chemotherapy improves the survival outcome in patients with muscle invasive bladder cancer
    Wong, H. L.
    Yeung, V. H. W.
    Lee, Y. K.
    Chu, P. S. K.
    Man, C. W.
    Lee, K. C.
    INTERNATIONAL JOURNAL OF UROLOGY, 2017, 24 : 35 - 35
  • [2] NEOADJUVANT CHEMOTHERAPY RESULTS IN SKELETAL MUSCLE INDEX DECLINE IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER
    Steinsiek, Nikki
    Acevedo, Ann Martinez
    Guimaraes, Alexander
    Achim, Virginie
    Jones, Paul
    Bash, Jasper
    Whitaker, Makena
    Amling, Christopher L.
    Cetnar, Jeremy
    Liu, Jen-Jane
    JOURNAL OF UROLOGY, 2018, 199 (04): : E531 - E531
  • [3] Impact of histology and toxicities on outcomes of patients with muscle invasive bladder cancer receiving neoadjuvant chemotherapy
    Curran, Catherine
    Pond, Gregory Russell
    Acosta, Andres
    Nassar, Amin
    Abou Alaiwi, Sarah
    Ingham, Matthew D.
    Preston, Mark A.
    Steele, Graeme S.
    Kilbridge, Kerry L.
    McGregor, Bradley Alexander
    Mossanen, Matthew
    Sonpavde, Guru
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [4] ETIOLOGY OF TREATMENT DELAYS IN PATIENTS RECEIVING NEOADJUVANT CHEMOTHERAPY FOR MUSCLE-INVASIVE BLADDER CANCER
    El-Arabi, Ahmad
    Sherman, Garth
    Holzbeierlein, Jeffrey
    Lee, Eugene
    Wulff-Burchfield, Elizabeth
    JOURNAL OF UROLOGY, 2019, 201 (04): : E1025 - E1026
  • [5] Etiology of Treatment Delays in Patients Receiving Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
    El-Arabi, Ahmad M.
    Alam, Syed M.
    Sherman, Garth
    Parker, William P.
    Thompson, Jeffrey
    Holzbeierlein, Jeffrey M.
    Lee, Eugene K.
    Wulff-Burchfield, Elizabeth M.
    BLADDER CANCER, 2020, 6 (04) : 435 - 444
  • [6] NEOADJUVANT CHEMOTHERAPY IN MUSCLE INVASIVE BLADDER CANCER
    Hazhir, Samad
    INTERNATIONAL JOURNAL OF UROLOGY, 2014, 21 : A54 - A54
  • [7] Neoadjuvant chemotherapy in muscle invasive bladder cancer
    Suer, Evren
    Turkolmez, Kadir
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2012, 11 (01): : 74 - 78
  • [8] MOLECULAR PREDICTORS OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY AND PROGNOSIS IN MUSCLE-INVASIVE BLADDER CANCER
    Ragonese, Mauro
    Di Gianfrancesco, Luca
    Schinzari, Giovanni
    Palermo, Giuseppe
    Racioppi, Marco
    Bassi, PierFrancesco
    JOURNAL OF UROLOGY, 2019, 201 (04): : E1024 - E1025
  • [9] Neoadjuvant and adjuvant chemotherapy for muscle invasive bladder cancer
    Karaoglu, Aziz
    Oflazoglu, Utku
    Demir, Necla
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2013, 12 (01): : 58 - 63
  • [10] Survival Outcomes in Patients With Muscle-Invasive Bladder Cancer Receiving Neoadjuvant Chemotherapy Stratified by Number of Cycles
    Chakraborty, Anumita
    Hasler, Jill
    Handorf, Elizabeth
    Anari, Fern
    Ghatalia, Pooja
    Miron, Benjamin
    Plimack, Elizabeth R.
    Geynisman, Daniel M.
    Zibelman, Matthew
    CLINICAL GENITOURINARY CANCER, 2024, 22 (06)
12345